Y-Intercept »

4d Molecular Therapeutics In shares owned by Y-Intercept

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Y-Intercept

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 25k 10.81
2024-06-30 $284k 14k 20.99

More positions owned by Y-Intercept

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Jd.com Spon Ads Cl A (JD)
Spotify Technology S A SHS (SPOT)
Eli Lilly & Co. (LLY)
Ke Hldgs Sponsored Ads (BEKE)
Vale S A Sponsored Ads (VALE)
Otis Worldwide Corp (OTIS)
Microstrategy Cl A New (MSTR)
CVS Caremark Corporation (CVS)
Carrier Global Corporation (CARR)
Regeneron Pharmaceuticals (REGN)
Arthur J. Gallagher & Co. (AJG)
D.R. Horton (DHI)
Comcast Corp Cl A (CMCSA)

View all positions for Y-Intercept

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In